# Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

> **NCT00001582** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 902 (actual)

## Conditions studied

- T-cell Lymphoma
- B-Cell Lymphoma
- ATL
- Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001582
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1997-06-07
- **Primary completion:** 2023-03-17
- **Final completion:** 2023-03-17
- **Target enrollment:** 902 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001582, "Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00001582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*